Multilayer cured-entrapped microcapsule, preparation method therefor and use thereof
By employing multi-layer solidification and encapsulation technology, using an oil-phase intermediate protective solution of MCT oil and lecithin, and a natural polysaccharide shell, the stability and release control issues of microcapsules when encapsulating heat-sensitive active ingredients are solved, achieving high stability and controllable release, and making it suitable for various food dosage forms.
Patent Information
- Application Number
- PCT/CN2026/072275
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-13
- Filing Date
- 2026-01-13
- Publication Date
- 2026-11-19
AI Technical Summary
Existing microencapsulation technology has problems such as high heat inactivation rate and poor storage stability when encapsulating heat-sensitive active ingredients such as probiotics, especially during spray drying, which results in a short storage time.
A multilayer curing and embedding technology was adopted, using a mixture of MCT oil and lecithin as an intermediate protective liquid in the oil phase, combined with natural polysaccharides and porous composite powder to form a polysaccharide-based fast-dissolving shell, and microcapsules were prepared by low-temperature multilayer curing process to construct a honeycomb freeze-dried framework, thereby enhancing stability and release control.
It significantly improves the storage stability and bioavailability of heat-sensitive active ingredients, enables the controlled release of active ingredients in the digestive tract, enhances the market competitiveness and applicability of the product, and meets the requirements of green and sustainable development.
Smart Images

Figure CN2026072275_19112026_PF_FP_ABST
Abstract
Description
A multilayer solidified embedded microcapsule, its preparation method and application Technical Field
[0001] This application relates to the field of food processing technology, and more specifically, to a multilayer solidified encapsulated microcapsule, its preparation method, and its application. Background Technology
[0002] In recent years, encapsulation technology, characterized by its unique controlled release (slow release), isolation of active ingredients, taste masking, and toxicity reduction, has been increasingly widely used in the food, daily chemical, pharmaceutical, and agricultural industries. This encapsulation technology primarily utilizes microencapsulation, which involves encapsulating active ingredients within microcapsules with specific surface properties. During use, based on the principle of slow release, the active ingredients are gradually released from the microcapsules at a predetermined rate. The active ingredients are mainly probiotics, functional oils, vitamins, fragrance essential oils, and natural active ingredients.
[0003] Microencapsulation of probiotics has been a research hotspot both domestically and internationally, as it can reduce the damage to cells caused by the external environment. Chinese invention patent application CN2018116351025 discloses a probiotic encapsulation particle, using probiotics as the core, encapsulated layer by layer with starch and water, followed by film coating and enteric coating, and then spray drying. However, during spray drying, the short-term high temperature and high-speed atomization can lead to the inactivation of a large number of bacteria. Furthermore, the moisture content of spray-dried microcapsules is higher than that of freeze-dried microcapsules, making them prone to moisture absorption and accelerated bacterial death. This results in poor storage stability and a short shelf life. Therefore, spray drying is not suitable for encapsulating heat-sensitive active ingredients such as probiotics.
[0004] In response to the aforementioned technologies, the inventors discovered an urgent need for a microcapsule preparation method that reduces the thermal inactivation of heat-sensitive active ingredients such as probiotics and improves their stability. Summary of the Invention
[0005] To increase the stability of heat-sensitive active ingredients such as probiotics and reduce thermal inactivation during encapsulation, this application provides a multilayer solidified encapsulated microcapsule, its preparation method, and its application.
[0006] In a first aspect, this application provides a method for preparing multilayer solidified embedded microcapsules, employing the following technical solution:
[0007] A method for preparing multilayer solidified embedded microcapsules includes the following steps:
[0008] Preparation of oil-phase intermediate protective liquid: MCT oil and lecithin are mixed, heated to 50-60℃ to melt, and homogenized at 20-30MPa to obtain oil-phase intermediate protective liquid;
[0009] Preparation of polysaccharide-based shell liquid: Mix natural polysaccharides with water, heat to 50-60℃ to dissolve, add β-glucan, thickener, citric acid, flavoring and filler, mix and homogenize to prepare polysaccharide-based shell liquid;
[0010] Emulsification: The oil phase intermediate protective liquid was added to the polysaccharide shell liquid, stirred, and homogenized at 28-30 MPa to obtain a blended emulsion;
[0011] Powder mixing: Maltodextrin and mannan oligosaccharide are mixed and spray-dried to obtain a porous composite powder with a moisture content of ≤1.5%. The porous composite powder is then mixed evenly with the core active ingredient to obtain the powder. The core active ingredient is selected from at least one of the following: polypeptides, vitamins, probiotics, polysaccharides, fermentation metabolites, enzymes, volatile oils, menthol, allicin, amino acid derivatives, lutein, astaxanthin, and heat-sensitive plant powders.
[0012] Composite curing: The powder and the blended emulsion are vacuum mixed to obtain a blended liquid, which is then injected into a mold. After being flash-frozen with liquid nitrogen, the mixture is kept at a temperature of -40 to 5℃ and a vacuum degree of 50 to 100 Pa for 10 to 12 hours. Then, it is kept at a temperature of -5 to 45℃ and a vacuum degree of 10 to 30 Pa for 8 to 10 hours until the water content in the microcapsules is ≤1.5%.
[0013] By employing the above technical solution, a mixture of MCT oil and lecithin is used as the intermediate protective liquid in the oil phase. MCT oil is transported directly via the portal vein, eliminating the need for bile salt emulsification, thus reducing the digestive burden. Furthermore, its high solubility makes it suitable for loading fat-soluble components such as vitamin D and coenzyme Q10, which are core active ingredients. Its freezing point is -40℃, providing good low-temperature fluidity and ensuring uniform coating of the core active ingredients during liquid nitrogen flash freezing. Lecithin, a natural emulsifier, reduces oil-water interfacial tension, increases emulsion stability, and its phospholipid bilayer structure protects the cell membrane integrity of the core active ingredients. Homogenizing the MCT oil and lecithin under high pressure yields an intermediate protective liquid with small and uniform particle size. Spray drying with mannan oligosaccharides and maltodextrin forms a porous composite powder with good fluidity, which can be used as a freeze-drying protectant. This agent enhances the freeze resistance of active ingredients and reduces the impact of low temperatures on them. Together with a shell made of natural polysaccharides, it constructs a honeycomb-like freeze-dried framework, resulting in shorter rehydration time and faster dissolution. Furthermore, the quick-dissolving polysaccharide shell forms a double polysaccharide barrier, reducing oxygen permeation and extending the shelf life of the active ingredients. A polysaccharide-based shell liquid is prepared using natural polysaccharides, thickeners, and β-glucan. Natural polysaccharides can form elastic hydrogels, improving the thixotropic properties of the emulsion. Moreover, the film-forming properties of natural polysaccharides enable the shell liquid to form a porous framework during liquid nitrogen flash freezing, accelerating rehydration. The quick-dissolving polysaccharide shell, primarily composed of natural polysaccharides, allows for controlled release of the microcapsules in the gastrointestinal environment, increasing the release and absorption rates of water-soluble active ingredients and prolonging the action time of the core active ingredients in the intestines. This solves the problems of poor oral efficacy and low absorption rate of existing microcapsules, thus improving therapeutic effects.
[0014] By employing low-temperature multilayer solidification and encapsulation technology, microcapsules containing a core active ingredient layer, an oil-phase intermediate protective layer, and a polysaccharide-based fast-dissolving outer shell are prepared. This effectively avoids degradation and inactivation problems caused by peptides, probiotics, vitamins, etc., thus significantly improving product storage stability and shelf life. In addition, by constructing an oil-phase intermediate protective layer, a lipid absorption environment can be simulated to promote the absorption of lipid-soluble components in the digestive tract. At the same time, the polysaccharide-based fast-dissolving outer shell allows for controlled release in the gastrointestinal environment, improving the release and absorption rates of water-soluble components. This solves the problem of "poor oral efficacy and low absorption rate" of existing microcapsules and enhances the bioavailability of heat-sensitive components. Furthermore, by adjusting the raw material selection of the encapsulation wall material, precise control of the release rate of the core active ingredient can be achieved. This is suitable for functional products that require staged release or intestinal-targeted release, and is significantly superior to traditional single-layer mixed tablets or powders. This formulation is suitable for a variety of nutritional functional factors, and exhibits excellent compatibility with natural extracts and fermentation metabolites that are structurally complex, poorly compatible, or have low stability. Through structural regulation, it can accommodate acidic / alkaline components and hydrophilic / hydrophobic substances. The formulation system is highly flexible, significantly expanding the range of product formulations and suitable for different functional needs. The active ingredients and sustained-release rate can be freely adjusted according to the usage scenario. Furthermore, the resulting microcapsule particles possess good mechanical strength and rapid solubility, making them suitable for various health food dosage forms such as solid beverages, compressed candies, energy bars, capsules, and effervescent tablets. This meets the functional needs of different consumer groups and scenarios, enhancing market competitiveness. It aligns with green and sustainable development trends, as the encapsulation materials used are all food-grade natural substances or renewable resources. The process requires no organic solvents or high-energy-consuming treatments, complying with clean production and environmental protection policies, and possessing promising prospects for industrial transformation.
[0015] Optionally, the mass percentages of each raw material, based on the weight of the microcapsules, are as follows:
[0016] Maltodextrin 6-7%, mannan oligosaccharide 3-5%, core active ingredient 8-10%, MCT oil 8-9%, lecithin 1-2%, β-glucan 5-7%, thickener 0.8-1%, citric acid 0.3-0.5%, flavoring 0.4-1%, filler 5-6%, balance is natural polysaccharide.
[0017] By adopting the above technical solution, the raw materials in the above proportions can be encapsulated using ultra-low temperature multilayer solidification technology to obtain a polysaccharide-based fast-dissolving outer shell layer with core active ingredients, maltodextrin, and mannan oligosaccharides as the core layer, MCT oil and lecithin as the oil phase intermediate protective layer, and natural polysaccharides as the main component. Appropriate dosage of active ingredients avoids overcrowding within the core layer, which could affect activity and stability. Adjusting the dosage of raw materials avoids an excessively thick outer shell layer, which could hinder the release and absorption of the core active ingredients in the intestines, preventing timely dissolution of chemical components and affecting release and absorption. Conversely, an excessively thin outer shell layer can also be avoided. Effective control of the release rate of active ingredients can lead to rapid release, but insufficient protection can cause them to become inactive before reaching the intestines. The oil-phase intermediate protective layer primarily serves as an isolation and protection layer. An appropriate amount can prevent the active ingredients from contacting adverse external environments, reducing damage and improving the stability of the microcapsules. However, excessive oil-phase protective layer can affect the solubility of the capsules and the release of active ingredients, while insufficient oil-phase protective layer will fail to effectively isolate external factors, reduce capsule stability, and decrease its regulatory effect on the release of active ingredients.
[0018] Optionally, the mass ratio of the maltodextrin to mannan oligosaccharide is 2:1.
[0019] By adopting the above technical solution, porous composite powder is prepared by spray drying using maltodextrin and mannan oligosaccharides. Maltodextrin plays a filling and supporting role during the drying process. However, excessive maltodextrin will cause the internal structure of the material to be too dense and reduce the porosity. If the amount is too small, a stable structure cannot be formed after drying, and the strength is insufficient, making it difficult to protect the core active ingredients. Mannan oligosaccharides help to form a porous structure and increase the porosity. If the amount is insufficient, it cannot promote the formation of pores, resulting in a low porosity.
[0020] Optionally, the natural polysaccharide is selected from at least one of gum arabic, sorbitol, maltodextrin, pectin, agar, starch, and chitosan.
[0021] By adopting the above technical solutions, the various natural polysaccharides can form a dense physical barrier, slow down the direct contact between active ingredients and the outside world, control the release rate of active ingredients, and the synergistic effect of different polysaccharides can increase the utilization rate of active ingredients in the intestine.
[0022] Optionally, the natural polysaccharide comprises gum arabic and sorbitol in a mass ratio of 1:1-1.5.
[0023] By adopting the above technical solution, the complex of gum arabic and sorbitol can form a protective film around the intermediate protective layer of the oil phase, slowing down the release of the core active ingredient and avoiding interference from factors such as temperature and humidity. Gum arabic and sorbitol are highly safe, harmless to the human body, and do not cause adverse reactions, creating a good foundation for the absorption of the core active ingredient in the gastrointestinal tract. Before entering the human intestine, the outer shell formed by gum arabic and sorbitol can protect the core active ingredient from damage by gastric acid and choline, improving the survival rate of the core active ingredient after reaching the intestine. Moreover, gum arabic itself is a high-quality prebiotic component. Its molecules are larger than those of fructooligosaccharides, which to some extent prolongs the digestion time, resulting in high digestive comfort and good tolerance. It can provide nutrients for probiotics when they are used as the core active ingredient, promoting the growth and reproduction of probiotics in the intestine, thereby maintaining the activity of probiotics.
[0024] Optionally, the thickener is selected from at least one of xanthan gum, guar gum, locust bean gum, konjac gum, gelatin, gellan gum, sodium polyacrylate, sodium carboxymethyl cellulose, and sodium carboxymethyl starch;
[0025] The filler is calcium carbonate or diatomaceous earth;
[0026] The lecithin is selected from at least one of sunflower lecithin, soybean lecithin, egg yolk lecithin, and milk lecithin.
[0027] By adopting the above technical solution and using xanthan gum, guar gum, etc. as thickeners, it is possible to increase...
[0028] Optionally, the lecithin is pretreated with glycerol, specifically by mixing lecithin and glycerol at a mass ratio of 1:0.5 and mixing at 60-65°C for 20-30 minutes.
[0029] By adopting the above technical solution, glycerol is used to prehydrate lecithin, which improves the emulsification effect of lecithin, balances the emulsification and fluidity, and improves the elasticity and hardness of the intermediate protective layer in the oil phase. This makes the hardness temperature and disintegration time of the microcapsules stable. In addition, glycerol has good moisturizing and stability properties, which can absorb moisture and keep the humidity of the core active ingredients stable, thus extending the shelf life. At the same time, glycerol can also regulate the release of drugs, achieving a better sustained-release effect.
[0030] Optionally, the enzyme is superoxide dismutase or lysozyme, the volatile oil is selected from at least one of peppermint oil, bay leaf oil, clove oil, cinnamon oil, and mugwort oil, the probiotic is selected from one or more of Lactobacillus and Bifidobacterium, the fermentation metabolite is one or more of nattokinase and red yeast rice metabolites, and the polypeptide is one or more of glutathione and collagen peptides.
[0031] Optionally, the heat-sensitive plant powder is selected from at least one of Ganoderma lucidum powder, kudzu root powder, Rhodiola rosea powder, Tremella fuciformis powder, ginseng powder, Astragalus membranaceus powder, rose powder, and chrysanthemum powder.
[0032] Optionally, the mass percentages of each raw material, based on the weight of the microcapsules, are as follows:
[0033] Maltodextrin 6%, mannan oligosaccharide 3%, Lactobacillus paracasei 10%, MCT oil 8%, lecithin 2%, β-glucan 5%, xanthan gum 1%, citric acid 0.5%, flavoring 1%, filler 5%, gum arabic 23.4% and sorbitol 35.1%.
[0034] By adopting the above technical solution, using Lactobacillus paracasei as the core active ingredient, and using maltodextrin and mannan oligosaccharides to cryoprotect Lactobacillus paracasei, and using gum arabic and sorbitol as natural polysaccharides, an instant-dissolving outer shell is obtained. This shell can bind to receptors on the surface of the intestinal mucosa, enhance the adhesion of the probiotic capsules in the intestine, improve the colonization ability and activity of Lactobacillus paracasei in the intestine, enhance the absorption effect, prolong the residence time of probiotics in the intestine, and thus improve the absorption rate.
[0035] Optionally, the viable count of Lactobacillus paracasei is ≥1.2 × 10⁻⁶. 11 cfu / g.
[0036] Optionally, before injecting the blend into the mold, a protective liquid is added to the blend, homogenized, cooled, and then injected into the mold. The protective liquid is a chitosan acetic acid solution containing glycyrrhizic acid powder, and the amount of protective liquid is 5-10% of the amount of the core active ingredient.
[0037] By adopting the above technical solution, glycyrrhizic acid powder possesses self-assembly characteristics and is a natural amphiphilic saponin with advantages such as good foaming properties, good stability, and high porosity. In the core active ingredient liquid, it undergoes multi-layer adsorption at the interface, forming a fibrous network around the bubbles and improving the viscoelasticity of the core active ingredient liquid, effectively preventing liquid leakage and foaming. This results in a larger encapsulation of the active ingredient in the microcapsules. Chitosan is uniformly distributed in the polysaccharide-based outer shell liquid. The self-assembly of glycyrrhizic acid and the entanglement of glycyrrhizic acid nanofibers with chitosan through hydrogen bonds form a compact and ordered composite hydrogel network. Therefore, chitosan can enhance the fiber network of glycyrrhizic acid nanofibers, resulting in gel foam with good dimensional stability and increased fiber network compactness. After freeze-forming, a porous material is obtained. The rich pore structure can reduce the core active ingredient... The increased contact area with the external environment improves storage stability. Furthermore, the porous material acts as a physical barrier, reducing contact between cells and ice crystals and mitigating the impact of freeze-drying on the core active ingredients. The hydroxyl and amino groups on the chitosan molecular chain can form hydrogen bonds or electrostatic interactions with the probiotic cell membrane. During freezing, this physical coating may reduce mechanical damage to cells from ice crystals, increasing the survival rate of probiotics. Chitosan swells at the intestinal pH (6.5-7.4), delaying the release of active ingredients. Simultaneously, the chitosan membrane blocks water molecule permeation, reducing the water absorption rate of the microcapsules and enhancing storage stability. Glycyrrhizic acid powder, through covalent cross-linking with chitosan, increases the stability of the chitosan membrane, further enhancing storage stability and reducing peroxide value. Glycyrrhizic acid also inhibits the growth of unwanted bacteria, extending shelf life and neutralizing the acidity of chitosan, reducing acid damage to probiotics.
[0038] Optionally, the mass ratio of glycyrrhizic acid powder to chitosan is 1:4, and the concentration of the chitosan acetic acid solution is 1.5-2 wt%.
[0039] By adopting the above technical solutions, an appropriate chitosan acetic acid solution has good film-forming ability, while the amount of glycyrrhizic acid powder added affects the film-forming properties of chitosan.
[0040] Secondly, this application provides a multilayer solidified embedded microcapsule, employing the following technical solution:
[0041] A multilayer solidified embedded microcapsule is prepared by a method for preparing multilayer solidified embedded microcapsules.
[0042] Thirdly, this application provides an application of multilayer solidified embedded microcapsules, employing the following technical solution:
[0043] Application of a multilayer solidified encapsulated microcapsule in powders, energy bars, tablets or capsules.
[0044] By adopting the above technical solution, the microcapsules prepared by low-temperature multilayer solidification and encapsulation have the advantages of high mechanical strength and good dissolution effect, and can be used in various food dosage forms such as solid beverages, compressed candies, and effervescent tablets, which can meet the needs of different consumer groups.
[0045] In summary, this application has the following beneficial effects:
[0046] 1. Because this application uses low-temperature multilayer solidification and encapsulation technology to produce microcapsules with multilayer structures, the microcapsules have good structural density and solubility, solving the core pain points of existing microcapsules in terms of stability and absorption rate. They also have sustained-release regulation capabilities and broad component compatibility and formulation adaptability, which can improve the stability of active ingredients, enhance bioavailability, support the development of diverse dosage forms, and conform to the trend of green and sustainable development. Through innovative structural design and preparation process, multiple functional improvements of the product are achieved, which has significant technical promotion value and commercial application potential.
[0047] 2. In this application, gum arabic and sorbitol are preferred as natural polysaccharides, which are combined with β-glucan, thickeners and other agents to prepare a polysaccharide quick-dissolving shell, which can be released in a controlled manner in the gastrointestinal tract, increasing the release rate and absorption effect. In addition, maltodextrin and mannan oligosaccharides are used as cryoprotectants for the core active ingredients, which can reduce the freezing damage of ice crystals to the active ingredients.
[0048] 3. In this application, a protective solution is preferably added to the blend containing the core active ingredient, oil phase and natural polysaccharide. The protective solution contains glycyrrhizic acid powder and chitosan acetic acid solution, which can provide further protection against frost damage to the active ingredient, and can also reduce water absorption and increase storage stability. Attached Figure Description
[0049] Figure 1 is a scanning electron microscope (SEM) image of the multilayer solidified embedded microcapsules in Example 1. Detailed Implementation
[0050] The following embodiments provide a further detailed description of this application.
[0051] Example
[0052] Example 1: A method for preparing multilayer solidified embedded microcapsules, comprising the following steps:
[0053] S1. Preparation of oil-phase intermediate protective solution: Mix 8g MCT oil and 2g sunflower lecithin, heat to 60℃ to melt, and homogenize 3 times at 20MPa to obtain oil-phase intermediate protective solution. Sunflower lecithin is pretreated with glycerol by mixing sunflower lecithin and glycerol at a mass ratio of 1:0.5 and mixing at 60℃ for 30min.
[0054] S2. Preparation of polysaccharide-based shell liquid: Mix 58.5g of natural polysaccharide (containing 23.4g of gum arabic and 35.1g of sorbitol) with water, heat to 60℃ to dissolve, and obtain a sugar solution with a concentration of 1wt%. Add 5g of β-glucan, 1g of thickener xanthan gum, 0.5g of citric acid, 1g of lemon flavoring and 5g of filler food-grade diatomaceous earth to the sugar solution, mix and homogenize to obtain the polysaccharide-based shell liquid;
[0055] S3. Emulsification: Add the oil phase intermediate protective liquid to the polysaccharide shell liquid, stir at 10000 r / min for 5 min, and then homogenize at 30 MPa for 3 min to obtain a blended emulsion.
[0056] S4. Powder Mixing: Mix 6g of maltodextrin and 3g of mannan oligosaccharide, and spray dry under conditions of 160℃ inlet air and 80℃ outlet air to obtain a porous composite powder with a moisture content ≤1.5%; using Lactobacillus paracasei as the core active ingredient, inoculate Lactobacillus paracasei into MRS liquid medium and culture until the viable count reaches 1.2×10⁻⁶ cells / 10g. 11 The cfu / g Lactobacillus paracasei was mixed evenly with the prepared porous composite powder to obtain the powder. The Lactobacillus paracasei was selected from Xi'an Ganyecao Biotechnology Co., Ltd., with the product number Y-019.
[0057] S5. Composite curing: The powder and the blended emulsion are vacuum mixed to obtain a blended liquid, which is then injected into a mold. After cooling with liquid nitrogen at -70℃ for 5 minutes, it is kept at -40℃ and 100Pa vacuum for 12 hours. Then, it is kept at -5℃ and 30Pa vacuum for 10 hours until the moisture content of the microcapsules is ≤1.5%.
[0058] Table 1. Raw material usage of microcapsules in Examples 1-5
[0059] Example 2: A method for preparing multilayer solidified embedded microcapsules, comprising the following steps:
[0060] S1. Preparation of oil-phase intermediate protective solution: Mix 9g MCT oil and 1g sunflower lecithin, heat to 50℃ to melt, and homogenize twice at 30MPa to obtain oil-phase intermediate protective solution. Sunflower lecithin is pretreated with glycerol by mixing sunflower lecithin and glycerol at a mass ratio of 1:0.5 and mixing at 65℃ for 20min.
[0061] S2. Preparation of polysaccharide-based shell liquid: Mix 58.5g of natural polysaccharide (containing 23.4g of gum arabic and 35.1g of sorbitol) with water, heat to 50℃ to dissolve, and obtain a sugar solution with a concentration of 1wt%. Add 7g of β-glucan, 0.8g of thickener xanthan gum, 0.3g of citric acid, 0.4g of lemon flavor and 6g of filler food-grade diatomaceous earth to the sugar solution, mix and homogenize to obtain the polysaccharide-based shell liquid;
[0062] S3. Emulsification: Add the oil phase intermediate protective liquid to the polysaccharide shell liquid, stir at 10000 r / min for 5 min, and then homogenize at 20 MPa for 5 min to obtain a blended emulsion.
[0063] S4. Powder Mixing: Mix 6g of maltodextrin and 3g of mannan oligosaccharide, and spray dry under conditions of 160℃ inlet air and 80℃ outlet air to obtain a porous composite powder with a moisture content ≤1.5%; using Lactobacillus paracasei as the core active ingredient, inoculate Lactobacillus paracasei into MRS liquid medium and culture it to achieve a viable count of 1.2×10⁸ cells / g. 11 The cfu / g Lactobacillus paracasei was mixed evenly with the prepared porous composite powder to obtain the powder. The Lactobacillus paracasei was selected from Xi'an Ganyecao Biotechnology Co., Ltd., with the product number Y-019.
[0064] S5. Composite curing: The powder and the blended emulsion are vacuum mixed to obtain a blended liquid, which is then injected into a mold. After cooling with liquid nitrogen at -70℃ for 5 minutes, the mixture is kept at -5℃ and 50Pa for 10 hours. Then, it is kept at 45℃ and 10Pa for 10 hours until the moisture content of the microcapsules is ≤1.5%.
[0065] Example 3: A method for preparing multilayer solidified embedded microcapsules, which differs from Example 1 in that the raw material amounts are shown in Table 1, and the mass ratio of maltodextrin to mannan oligosaccharide is 7:5.
[0066] Example 4: A method for preparing multilayer solidified embedded microcapsules, the difference from Example 1 is that the natural polysaccharides include gum arabic and sorbitan in a mass ratio of 1:1.
[0067] Example 5: A method for preparing multilayer solidified embedded microcapsules, the difference from Example 1 is that the natural polysaccharides include 38.5g gum arabic and 20g sorbitan.
[0068] Example 6: A method for preparing multilayer solidified embedded microcapsules, the difference from Example 1 is that the natural polysaccharide is pectin.
[0069] Example 7: A method for preparing multilayer solidified embedded microcapsules, differing from Example 1 in that, before injecting the blend into the mold in step S5, a protective solution is added to the blend, homogenized at 20,000 rpm for 2 min, and then rapidly cooled in an ice-water bath at 2°C for 10 min. The protective solution is prepared by adding chitosan to a 1% acetic acid solution to obtain a 2wt% chitosan-acetic acid solution, adding glycyrrhizic acid powder to it, mixing evenly, and obtaining the protective solution. The mass ratio of glycyrrhizic acid powder to chitosan is 1:4, and the amount of protective solution used is 10% of the mass of Lactobacillus paracasei.
[0070] Example 8: A method for preparing multilayer solidified embedded microcapsules, the difference from Example 1 is that, before injecting the blend into the mold in step S5, a protective liquid is added to the blend, homogenized at 20000 rpm for 2 min, and then rapidly cooled in an ice-water bath at 2℃ for 10 min. The protective liquid is prepared by adding chitosan to a 1% acetic acid solution to obtain a 1.5 wt% chitosan acetic acid solution, adding glycyrrhizic acid powder to it, mixing evenly to obtain the protective liquid, the mass ratio of glycyrrhizic acid powder to chitosan is 1:4, and the amount of protective liquid used is 5% of the mass of Lactobacillus paracasei.
[0071] Example 9: A method for preparing multilayer solidified embedded microcapsules, which differs from Example 7 in that, before injecting the blend into the mold in step S5, a protective solution is added to the blend, homogenized at 20,000 rpm for 2 min, and then rapidly cooled in an ice-water bath at 2°C for 10 min. The protective solution is prepared by adding glycyrrhizic acid powder to water, dissolving it, and obtaining a protective solution with a concentration of 1.5 wt%. The amount of protective solution used is 5% of the mass of Lactobacillus paracasei.
[0072] Example 10: A method for preparing multilayer solidified embedded microcapsules, which differs from Example 7 in that, before injecting the blend into the mold in step S5, a protective liquid is added to the blend, homogenized at 20,000 rpm for 2 min, and then rapidly cooled in an ice-water bath at 2°C for 10 min. The protective liquid is prepared by adding chitosan to a 1% acetic acid solution to obtain a protective liquid with a concentration of 1.5 wt%, and the amount of protective liquid used is 5% of the mass of Lactobacillus paracasei.
[0073] Comparative Example
[0074] Comparative Example 1: A method for preparing solidified and embedded microcapsules, comprising the following steps:
[0075] S1. Preparation of polysaccharide-based shell liquid: Mix 58.5g of natural polysaccharide (containing 23.4g of gum arabic and 35.1g of sorbitol) with water, heat to 60℃ to dissolve, and obtain a sugar solution with a concentration of 1wt%. Add 5g of β-glucan, 1g of thickener xanthan gum, 0.5g of citric acid, 1g of lemon flavor and 5g of filler food-grade diatomaceous earth to the sugar solution, mix and homogenize to obtain the polysaccharide-based shell liquid;
[0076] S2. Powder Mixing: Mix 6g of maltodextrin and 3g of mannan oligosaccharide, and spray dry under conditions of 160℃ inlet air and 80℃ outlet air to obtain a porous composite powder with a moisture content ≤1.5%; using Lactobacillus paracasei as the core active ingredient, inoculate Lactobacillus paracasei into MRS liquid medium and culture until the viable count reaches 1.2×10⁻⁶ cells / 10g. 11 The cfu / g Lactobacillus paracasei was mixed evenly with the prepared porous composite powder to obtain the powder. The Lactobacillus paracasei was selected from Xi'an Ganyecao Biotechnology Co., Ltd., with the product number Y-019.
[0077] S3. Composite curing: The powder and polysaccharide shell liquid are vacuum mixed to obtain a blend liquid, which is then injected into a mold. After cooling with liquid nitrogen at -70℃ for 5 minutes, the mixture is kept at -40℃ and 100Pa vacuum for 12 hours. Then, it is kept at -5℃ and 30Pa vacuum for 10 hours until the water content of the microcapsules is ≤1.5%.
[0078] Comparative Example 2: A method for preparing solidified and embedded microcapsules, comprising the following steps:
[0079] S1. Preparation of oil phase protective solution: Mix 8g MCT oil and 2g sunflower lecithin, heat to 60℃ to melt, and homogenize 3 times at 20MPa to obtain oil phase protective solution. Sunflower lecithin is pretreated with glycerol by mixing sunflower lecithin and glycerol at a mass ratio of 1:0.5 and mixing at 60℃ for 30min.
[0080] S2. Powder Mixing: Mix 6g of maltodextrin and 3g of mannan oligosaccharide, and spray dry under conditions of 160℃ inlet air and 80℃ outlet air to obtain a porous composite powder with a moisture content ≤1.5%; using Lactobacillus paracasei as the core active ingredient, inoculate Lactobacillus paracasei into MRS liquid medium and culture until the viable count reaches 1.2×10⁻⁶ cells / 10g. 11 The cfu / g Lactobacillus paracasei was mixed evenly with the prepared porous composite powder to obtain the powder. The Lactobacillus paracasei was selected from Xi'an Ganyecao Biotechnology Co., Ltd., with the product number Y-019.
[0081] S3. Composite curing: The powder and the oil phase protective liquid are vacuum mixed to obtain a blended liquid, which is then injected into a mold. After cooling with liquid nitrogen at -70℃ for 5 minutes, it is kept at -40℃ and 100Pa vacuum for 12 hours. Then, it is kept at -5℃ and 30Pa vacuum for 10 hours until the moisture content of the microcapsules is ≤1.5%.
[0082] Comparative Example 3: A method for preparing multilayer solidified encapsulated microcapsules, differing from Example 1 in that step S4, powder mixing: using *Lactobacillus paracasei* as the core active ingredient, *Lactobacillus paracasei* is inoculated into MRS liquid culture medium and cultured until the viable count of 8g reaches 1.2 × 10⁸. 11 The cfu / g Lactobacillus paracasei was mixed evenly with 6g maltodextrin and 3g mannan oligosaccharide to obtain a powder.
[0083] Comparative Example 4: A method for preparing multilayer solidified embedded microcapsules, which differs from Example 1 in that spray drying is used instead of composite solidification in S5. The spray drying inlet air temperature is 150°C, the outlet air temperature is 75°C, and the feed flow rate is 6 ml / min.
[0084] Comparative Example 5: A method for preparing multilayer solidified embedded microcapsules, which differs from Example 1 in that freeze drying is used instead of composite solidification in S5. The freeze drying process is as follows: pre-freezing at -80℃ for 24h, and then freezing in a vacuum freeze dryer at -49℃ and -0.02MPa for 24h.
[0085] Performance testing
[0086] Microcapsules were prepared according to the method in the examples, and their performance was tested according to the following methods. The test results are recorded in Table 2.
[0087] 1. Dissolution rate: Place 1g of microcapsules in 100ml of pure water at 25℃, stir, and record the time for complete dissolution.
[0088] 2. Survival rate of Lactobacillus paracasei in the product: Take 1g of microcapsule, add it to 100ml of pure water, stir to dissolve, and then dilute it serially. Use a spiral plate inoculator to inoculate it into an MRS culture plate for counting and calculate the survival rate. Survival rate / % = number of live bacteria in microcapsules / initial number of live bacteria × 100%.
[0089] 3. Storage stability: The survival rate (%) of Lactobacillus paracasei in the microcapsules was observed after 60 days in an environment of 25℃. The survival rate / % = number of viable bacteria in the microcapsules after 60 days / initial number of viable bacteria × 100%. The moisture content was also tested. At the same time, the microcapsules were subjected to accelerated testing at 40℃ for 30 days, and the survival rate of Lactobacillus paracasei was observed. The survival rate / % = number of viable bacteria in the microcapsules after 40 days / initial number of viable bacteria × 100%. The moisture content was also tested.
[0090] 4. Artificial simulated intestinal fluid test: Add 9 mL of artificial simulated intestinal fluid to a sterile tube, adjust the pH to 6.8 with 1M sodium hydroxide, and add 1 g of microcapsules. Place the sterile container in a shaker and treat for 4 h at 37℃ and 180 r / min. Take 1 mL of the solution and immediately add it to 9 mL of phosphate buffer solution. Stir and shake at 37℃ for 1 h to allow the probiotic microparticles to fully depolymerize. Then, through serial dilution, inoculate the solution into MRS culture plates using a spiral plate inoculator for counting and calculate the release rate of Lactobacillus paracasei. Simulated intestinal fluid preparation method: Adjust the pH of 6.8 g / L KH2PO4 to 7.5 ± 0.1 with NaOH, sterilize, and add 10 g / L trypsin and 0.3 wt% bile salts; filter and sterilize as before.
[0091] 5. Artificial Gastric Fluid Simulation Test: 1 g of microcapsules was added to a 9 ml sterile tube containing simulated gastric fluid (pH 1.2). After incubation at 37°C for 2 h, 1 mL of the solution was immediately added to 9 mL of phosphate buffer solution and stirred at 37°C for 1 h to allow the probiotic microcapsules to fully depolymerize. Subsequently, the microcapsules were serially diluted and inoculated onto MRS culture plates using a spiral plate inoculator for counting. The release rate of Lactobacillus paracasei was calculated. The simulated gastric fluid formulation consisted of 9 g / L NaCl solution adjusted to pH 2.0 with hydrochloric acid, sterilized, and then 3.2 g / L of pepsin was added. The solution was then filtered through a 0.22 μm filter for sterilization.
[0092] Table 2 Performance test results of multilayer solidified embedded microcapsules
[0093] Continued from Table 2
[0094] Combining the data from Examples 1-2 and Table 2, it can be seen that using the amounts of raw materials in Examples 1 and 2 and employing low-temperature multilayer curing technology to prepare microcapsules, the resulting microcapsules exhibit excellent protective effects on active bacteria, far superior to the ordinary spray drying in Comparative Example 4 and the freeze-drying in Comparative Example 5. Moreover, compared to Comparative Example 2, which uses an oil phase as the outer shell, using gum arabic and sorbitan as natural polysaccharides to prepare a readily soluble polysaccharide outer shell improves the disintegration efficiency and resolubility of the microcapsules in water. Compared to Comparative Example 1, which did not have an intermediate oil phase protective layer and only used a readily soluble polysaccharide outer shell to encapsulate *Lactobacillus paracasei*, using an intermediate oil phase protective layer can slow down the gastric release of active bacteria and promote targeted release in the small intestine. In Comparative Example 3, no porous composite powder was prepared using maltodextrin and mannan oligosaccharides for freeze-drying protection of *Lactobacillus paracasei*, resulting in a decreased survival rate of active bacteria. This indicates that using maltodextrin and mannan oligosaccharides for freeze-drying protection of active bacteria can improve the survival rate of active bacteria.
[0095] Compared with Example 1, Example 3 changed the mass ratio of maltodextrin and mannan oligosaccharides in the porous composite powder. It can be seen that it has a similar freeze-drying protection effect as Example 1, with a high survival rate of active bacteria, long storage time at room temperature and high temperature, and good targeted release effect.
[0096] In Example 4, the natural polysaccharides were gum arabic and sorbitan in a mass ratio of 1:1. In Example 5, gum arabic and sorbitan were used in a mass ratio of 1.925:1. It can be seen that compared with Example 1, the protective effect of Examples 4 and 5 on active bacteria was slightly reduced, but they still had good room temperature storage stability and sustained-release performance.
[0097] In Example 6, pectin was used as a natural polysaccharide to prepare a polysaccharide quick-dissolving shell. As can be seen from the data in Table 2, its dissolution rate decreased, and the release rate in intestinal and gastric juices decreased. This indicates that using gum arabic and sorbitan to make a polysaccharide quick-dissolving shell can effectively improve the dissolution rate and resolubility of microcapsules, and improve the release rate of microcapsules in intestinal and gastrointestinal juices.
[0098] Compared with Example 1, Examples 7 and 8 also added a chitosan acetic acid solution containing glycyrrhizic acid powder to the blend. Although the dissolution rate of the microcapsules prepared in this way was slightly increased, the number of live bacteria in the microcapsule products increased and the survival rate increased, indicating that the protective effect on live bacteria was enhanced. Moreover, the number of live bacteria increased after storage at room temperature, the stability at room temperature was enhanced, and the gastrointestinal release rate was not affected.
[0099] In Example 9, an aqueous solution containing glycyrrhizic acid powder was used as a protective solution, while in Example 10, a chitosanacetic acid solution was used as a protective solution. It can be seen that the number of viable bacteria in the prepared microcapsule products decreased compared with that in Example 7, and the survival rate decreased. This indicates that using glycyrrhizic acid powder and chitosanacetic acid solution as protective solutions can increase the protection of active bacteria and increase the storage stability of microcapsules.
[0100] This specific embodiment is merely an explanation of this application and is not intended to limit it. After reading this specification, those skilled in the art can make modifications to this embodiment without contributing any inventive step, but such modifications are protected by patent law as long as they fall within the scope of the claims of this application.
Claims
1. A method for the preparation of a multilayer solidified-embedded microcapsule, characterized in that, Includes the following steps: Preparation of oil-phase intermediate protective solution: MCT oil and lecithin are mixed, heated to 50-60℃ to melt, and homogenized at 20-30MPa to obtain oil-phase intermediate protective solution; Preparation of polysaccharide-based shell liquid: Mix natural polysaccharides with water, heat to 50-60℃ to dissolve, add β-glucan, thickener, citric acid, flavoring and filler, mix and homogenize to prepare polysaccharide-based shell liquid; Emulsification: The oil phase intermediate protective liquid was added to the polysaccharide shell liquid, stirred, and homogenized at 28-30 MPa to obtain a blended emulsion; Powder mixing: Maltodextrin and mannan oligosaccharide are mixed and spray-dried to obtain a porous composite powder with a moisture content of ≤1.5%. The porous composite powder is then mixed evenly with the core active ingredient to obtain the powder. The core active ingredient is selected from at least one of the following: polypeptides, vitamins, probiotics, polysaccharides, fermentation metabolites, enzymes, volatile oils, menthol, allicin, amino acid derivatives, lutein, astaxanthin, and heat-sensitive plant powders. Composite curing: The powder and the blended emulsion are vacuum mixed to obtain a blended liquid, which is then injected into a mold. After being flash-frozen with liquid nitrogen, the mixture is kept at a temperature of -40 to 5℃ and a vacuum degree of 50 to 100 Pa for 10 to 12 hours. Then, it is kept at a temperature of -5 to 45℃ and a vacuum degree of 10 to 30 Pa for 8 to 10 hours until the water content in the microcapsules is ≤1.5%.
2. The method of claim 1, wherein the method further comprises, The mass percentages of each raw material, based on the weight of the microcapsules, are as follows: Maltodextrin 6-7%, mannan oligosaccharide 3-5%, core active ingredient 8-10%, MCT oil 8-9%, lecithin 1-2%, β-glucan 5-7%, thickener 0.8-1%, citric acid 0.3-0.5%, flavoring 0.4-1%, filler 5-6%, balance is natural polysaccharide.
3. The method of claim 2, wherein the method further comprises: The mass ratio of maltodextrin to mannan oligosaccharide is 2:
1.
4. The method of claim 1, wherein: The natural polysaccharide is selected from at least one of gum arabic, sorbitol, maltodextrin, pectin, agar, sodium alginate, starch, and chitosan.
5. The method of claim 4, wherein: The natural polysaccharide comprises gum arabic and sorbitol in a mass ratio of 1:1-1.
5.
6. The method of claim 1, wherein: The thickener is selected from at least one of xanthan gum, guar gum, locust bean gum, konjac gum, gelatin, gellan gum, sodium polyacrylate, sodium carboxymethyl cellulose, and sodium carboxymethyl starch; The filler is calcium carbonate or diatomaceous earth; The lecithin is selected from at least one of sunflower lecithin, soybean lecithin, egg yolk lecithin, and milk lecithin.
7. The method of claim 6, wherein the method further comprises: The lecithin is pretreated with glycerol. The specific method is as follows: lecithin and glycerol are mixed at a mass ratio of 1:0.5 and mixed at 60-65℃ for 20-30 minutes.
8. The method of claim 1, wherein: Before the blend is injected into the mold, a protective liquid is added to the blend, homogenized, cooled, and then injected into the mold. The protective liquid is a chitosan acetic acid solution containing glycyrrhizic acid powder, and the amount of protective liquid is 5-10% of the amount of the core active ingredient.
9. A multi-layered solidified-embedded microcapsule, characterized in that, It is prepared by the method of preparing multilayer solidified embedded microcapsules according to any one of claims 1-8.
10. The use of a multilayer solidified encapsulated microcapsule prepared by the preparation method according to any one of claims 1-8 in a powder, energy bar, tablet or capsule.
